Adams Respiratory Therapeutics

Adams Respiratory Therapeutics Profile and History

Adams Respiratory Therapeutics, Inc. is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter (OTC), and prescription pharmaceuticals for the treatment of respiratory disorders. The Company markets market six oral-solid OTC products for adults under its Mucinex brand, six products in its Mucinex line of products for children, two Mucinex nasal spray products, and two products under its Delsym brand. In July 2007, the Company expanded the Mucinex franchise with its first nasal spray product, Mucinex Full Force Nasal Spray. In August 2007, it also began to market a second nasal spray product, Mucinex Moisture Smart Nasal Spray. In October 2007, Adams Respiratory Therapeutics, Inc. announced that the United States Food and Drug Administration has approved its supplemental New Drug Application for a grape-flavored formulation of Delsym. In February 2008, the Company has been acquired by Reckitt Benckiser Group PLC.